International Journal of Health and Clinical Research

International Journal of Health and Clinical Research

Study of Clinical profile of newly diagnosed lupus nephritis in case of systemic lupus erythematosus

Yazarlar: Tushar Dhakate, Anjali Rajadhyaksha, Ramiz Panjwani

Cilt 4 , Sayı 10 , 2021 , Sayfalar 111-114

Konular:-

Anahtar Kelimeler:Lupus Nephritis ,Systemic lupus erythematosus,Enalbiopsy,NA

Özet: Introduction:Lupus Nephritis (LN) affects 25-60% of people with Systemic Lupus Erythematosus (SLE) within the first 5 years of disease onset. We conducted a prospective observational study to look into the demographic and clinical characteristics of newly diagnosed LN patients. Material and Methods: Our study included 50 newly diagnosed cases of LN. Results:The female-male ratio was 15.67:1. The majority of patients had LN of class IV (69.39 percent ). The most common symptoms were alopecia, oral ulcers, and arthritis. All 50 patients were ANA positive, with 54 percent having anti-ds- DNA positivity. Conclusion:The most common type of LN in our study was IV. Although extrarenal manifestations, primarily mucocutaneous and musculoskeletal, were present, urine examination should be performed more frequently at the time of LN diagnosis for early diagnosis and treatment.


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2021, title={Study of Clinical profile of newly diagnosed lupus nephritis in case of systemic lupus erythematosus}, volume={4}, number={111–114}, publisher={International Journal of Health and Clinical Research}, author={Tushar Dhakate,Anjali Rajadhyaksha,Ramiz Panjwani}, year={2021} }
APA
KOPYALA
Tushar Dhakate,Anjali Rajadhyaksha,Ramiz Panjwani. (2021). Study of Clinical profile of newly diagnosed lupus nephritis in case of systemic lupus erythematosus (Vol. 4). Vol. 4. International Journal of Health and Clinical Research.
MLA
KOPYALA
Tushar Dhakate,Anjali Rajadhyaksha,Ramiz Panjwani. Study of Clinical Profile of Newly Diagnosed Lupus Nephritis in Case of Systemic Lupus Erythematosus. no. 111–114, International Journal of Health and Clinical Research, 2021.